Soft Tissue Sarcoma Follow-up Imaging: Strategies to Distinguish Post-treatment Changes from Recurrence

Abstract

Soft tissue sarcomas encompass multiple entities with differing recurrence rates and follow-up intervals. The detection of recurrences and their differentiation from post-therapeutic changes is therefore complex, with a central role for the clinical radiologist. This article describes approved recommendations. Prerequisite is a precise knowledge of the current clinical management and surgical techniques. We review recurrence rates and treatment modalities. An adequate imaging technique is paramount, and comparison with previous imaging is highly recommended. We describe time-dependent therapy-related complications on magnetic resonance imaging compared with the spectrum of regular post-therapeutic changes. Early complications such as seromas, hematomas, and infections, late complications such as edema and fibrosis, and inflammatory pseudotumors are elucidated. The appearance of recurrences and radiation-associated sarcomas is contrasted with these changes. This systematic approach in follow-up imaging of soft tissue sarcoma patients will facilitate the differentiation of post-therapeutic changes from recurrences.

Keywords

sarcoma - recurrence - aftercare - magnetic resonance imaging - postoperative complications

Publikationsverlauf

Artikel online veröffentlicht:
11. Dezember 2020

• References

• 1 Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer 2017; 123 (15) 2802-2820
• 2 Coindre JM, Terrier P, Bui NB. et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14 (03) 869-877
• 3 Felderhof JM, Creutzberg CL, Putter H. et al. Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy. Acta Oncol 2013; 52 (04) 745-752
• 4 Gronchi A, Lo Vullo S, Colombo C. et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg 2010; 251 (03) 506-511
• 5 Vanhoenacker FM, Van Looveren K, Trap K. et al. Grading and characterization of soft tissue tumors on magnetic resonance imaging: the value of an expert second opinion report. Insights Imaging 2012; 3 (02) 131-138
• 6 Gantzer J, Di Marco A, Fabacher T. et al. Conformity to clinical practice guidelines at initial management in adult soft tissue and visceral tumors since the implementation of the NetSarc Network in eastern France. Oncologist 2019; 24 (08) e775-e783
• 7 Sekimizu M, Ogura K, Yasunaga H. et al. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan. BMC Cancer 2019; 19 (01) 657
• 8 Zagars GK, Ballo MT, Pisters PW. et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003; 97 (10) 2530-2543
• 9 Italiano A, Le Cesne A, Mendiboure J. et al. Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting. Cancer 2014; 120 (21) 3361-3369
• 10 Toulmonde M, Le Cesne A, Mendiboure J. et al. Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up. Cancer 2014; 120 (19) 3003-3006
• 11 Gronchi A, Strauss DC, Miceli R. et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS Working Group. Ann Surg 2016; 263 (05) 1002-1009
• 12 Smith HG, Memos N, Thomas JM, Smith MJ, Strauss DC, Hayes AJ. Patterns of disease relapse in primary extremity soft-tissue sarcoma. Br J Surg 2016; 103 (11) 1487-1496
• 13 Novais EN, Demiralp B, Alderete J, Larson MC, Rose PS, Sim FH. Do surgical margin and local recurrence influence survival in soft tissue sarcomas?. Clin Orthop Relat Res 2010; 468 (11) 3003-3011
• 14 Gerrand CH, Bell RS, Wunder JS. et al. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer 2003; 97 (02) 485-492
• 15 Qureshi YA, Huddy JR, Miller JD, Strauss DC, Thomas JM, Hayes AJ. Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment. Ann Surg Oncol 2012; 19 (03) 871-877
• 16 Wang L, Pretell-Mazzini J, Kerr DA. et al. MRI findings associated with microscopic residual tumor following unplanned excision of soft tissue sarcomas in the extremities. Skeletal Radiol 2018; 47 (02) 181-190
• 17 Sawamura C, Matsumoto S, Shimoji T, Tanizawa T, Ae K. What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?. Clin Orthop Relat Res 2012; 470 (03) 700-705
• 18 Traub F, Griffin AM, Wunder JS, Ferguson PC. Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. Cancer 2018; 124 (19) 3868-3875
• 19 Sabolch A, Feng M, Griffith K. et al. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol 2012; 35 (02) 151-157
• 20 Trovik CS, Bauer HC, Alvegård TA. et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000; 36 (06) 710-716
• 21 Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol 2013; 52 (04) 793-802
• 22 Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002; 235 (03) 424-434
• 23 Daigeler A, Zmarsly I, Hirsch T. et al. Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma. Br J Cancer 2014; 110 (06) 1456-1464
• 24 Liu CY, Yen CC, Chen WM. et al. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol 2010; 17 (08) 2102-2111
• 25 Gundle KR, Gupta S, Kafchinski L. et al. An analysis of tumor- and surgery-related factors that contribute to inadvertent positive margins following soft tissue sarcoma resection. Ann Surg Oncol 2017; 24 (08) 2137-2144
• 26 Shapeero LG, De Visschere PJ, Verstraete KL. et al. Post-treatment complications of soft tissue tumours. Eur J Radiol 2009; 69 (02) 209-221
• 27 Lazarides AL, Kerr DL, Nussbaum DP. et al. Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers?. Clin Orthop Relat Res 2019; 477 (04) 718-727
• 28 Benson C, Judson I. Role of expert centres in the management of sarcomas—a UK perspective. Eur J Cancer 2014; 50 (11) 1951-1956
• 29 Bagaria SP, Chang YH, Gray RJ, Ashman JB, Attia S, Wasif N. Improving long-term outcomes for patients with extra-abdominal soft tissue sarcoma regionalization to high-volume centers, improved compliance with guidelines or both?. Sarcoma 2018; 2018: 8141056
• 30 Salas S, Stoeckle E, Collin F. et al. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database. Eur J Cancer 2009; 45 (12) 2091-2102
• 31 Eilber FC, Rosen G, Nelson SD. et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003; 237 (02) 218-226
• 32 Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol 2003; 15 (04) 319-326
• 33 Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238 (03) 358-370 ; discussion 370–371
• 34 Peterson JJ, Kransdorf MJ, Bancroft LW, O'Connor MI. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol 2003; 32 (09) 493-503
• 35 Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57 (03) 739-747
• 36 Nakamura T, Abudu A, Murata H. et al. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis. Eur J Surg Oncol 2013; 39 (09) 1030-1035
• 37 Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D. Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?. Clin Orthop Relat Res 2010; 468 (11) 3012-3018
• 38 Willems SM, Debiec-Rychter M, Szuhai K, Hogendoorn PC, Sciot R. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 2006; 19 (03) 407-416
• 39 Fox MG, Bancroft LW, Peterson JJ, Kransdorf MJ, Terkonda SP, O'Connor MI. MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. AJR Am J Roentgenol 2006; 187 (03) 800-806
• 40 Magerkurth O, Girish G, Jacobson JA. et al. MR imaging appearances of soft tissue flaps following reconstructive surgery of the lower extremity. Korean J Radiol 2015; 16 (01) 160-168
• 41 Ghert MA, Davis AM, Griffin AM. et al. The surgical and functional outcome of limb-salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity. Ann Surg Oncol 2005; 12 (12) 1102-1110
• 42 Parrett BM, Talbot SG, Pribaz JJ, Lee BT. A review of local and regional flaps for distal leg reconstruction. J Reconstr Microsurg 2009; 25 (07) 445-455
• 43 Summer T, Bota O, Armbruster R, Münchow S, Dragu A. Soft tissue defects following tumor resection in the limbs and trunk: plastic reconstructive soft tissue and revision concepts. [in German]. Orthopade 2020; 49 (02) 169-176
• 44 Wortman JR, Tirumani SH, Jagannathan JP. et al. Radiation therapy for soft-tissue sarcomas: a primer for radiologists. Radiographics 2016; 36 (02) 554-572
• 45 Jebsen NL, Trovik CS, Bauer HC. et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys 2008; 71 (04) 1196-1203
• 46 Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol 2010; 101 (05) 345-350
• 47 Davis AM, O'Sullivan B, Turcotte R. et al; Canadian Sarcoma Group, NCI Canada Clinical Trial Group Randomized Trial. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005; 75 (01) 48-53
• 48 O'Sullivan B, Davis A. Five-year results of a randomized phase III trial of pre-operative vs postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2004;22(9007):
• 49 Choong PF, Petersen IA, Nascimento AG, Sim FH. Is radiotherapy important for low-grade soft tissue sarcoma of the extremity?. Clin Orthop Relat Res 2001; (387) 191-199
• 50 Kraus-Tiefenbacher US, Van Kampen M. Current trends in radiotherapy following surgical resection of soft-tissue sarcoma of the extremities and trunk. [in German]. Handchir Mikrochir Plast Chir 2015; 47 (02) 128-133
• 51 Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003; 56 (02) 482-488
• 52 O'Sullivan B, Davis AM, Turcotte R. et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002; 359 (9325): 2235-2241
• 53 Barkley Jr HT, Martin RG, Romsdahl MM, Lindberg R, Zagars GK. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys 1988; 14 (04) 693-699
• 54 Cannon CP, Ballo MT, Zagars GK. et al. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 2006; 107 (10) 2455-2461
• 55 Slump J, Bastiaannet E, Halka A. et al. Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: a systematic review and meta-analyses. J Plast Reconstr Aesthet Surg 2019; 72 (09) 1449-1464
• 56 Kepka L, DeLaney TF, Suit HD, Goldberg SI. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2005; 63 (03) 852-859
• 57 Brodowicz T, Schwameis E, Widder J. et al. Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma 2000; 4 (04) 151-160
• 58 Woll PJ, Reichardt P, Le Cesne A. et al; EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012; 13 (10) 1045-1054
• 59 Frustaci S, Gherlinzoni F, De Paoli A. et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001; 19 (05) 1238-1247
• 60 Chou YS, Liu CY, Chen WM. et al. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival. J Surg Oncol 2012; 106 (02) 155-161
• 61 Cheney MD, Giraud C, Goldberg SI. et al. MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol 2014; 109 (06) 593-596
• 62 Hovgaard TB, Nymark T, Skov O, Petersen MM. Follow-up after initial surgical treatment of soft tissue sarcomas in the extremities and trunk wall. Acta Oncol 2017; 56 (07) 1004-1012
• 63 Park JW, Yoo HJ, Kim HS. et al. MRI surveillance for local recurrence in extremity soft tissue sarcoma. Eur J Surg Oncol 2019; 45 (02) 268-274
• 64 George A, Grimer RJ, James SLJ. Could routine magnetic resonance imaging detect local recurrence of musculoskeletal sarcomas earlier? a cost-effectiveness study. Indian J Orthop 2018; 52 (01) 81-86
• 65 Hirschmann A, van Praag VM, Haas RL, van de Sande MAJ, Bloem JL. Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?. Eur Radiol 2020; 30 (09) 4724-4733
• 66 Patel SA, Royce TJ, Barysauskas CM, Thornton KA, Raut CP, Baldini EH. Surveillance imaging patterns and outcomes following radiation therapy and radical resection for localized extremity and trunk soft tissue sarcoma. Ann Surg Oncol 2017; 24 (06) 1588-1595
• 67 Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin 2004; 54 (02) 94-109
• 68 Gibbs JF, Lee RJ, Driscoll DL, McGrath BE, Mindell ER, Kraybill WG. Clinical importance of late recurrence in soft-tissue sarcomas. J Surg Oncol 2000; 73 (02) 81-86
• 69 Maretty-Nielsen K, Aggerholm-Pedersen N, Safwat A. et al. Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: a cohort study of 922 consecutive patients. Acta Orthop 2014; 85 (03) 323-332
• 70 Roberts CC, Kransdorf MJ, Beaman FD. et al. ACR appropriateness criteria follow-up of malignant or aggressive musculoskeletal tumors. J Am Coll Radiol 2016; 13 (04) 389-400
• 71 Casali PG, Abecassis N, Aro HT. et al; ESMO Guidelines Committee and EURACAN. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29 (Suppl. 04) iv51-iv67
• 72 Noebauer-Huhmann IM, Weber MA, Lalam RK. et al. Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol 2015; 19 (05) 475-482
• 73 Mehren MV. NCCN clinical practice guidelines in oncology (NCCN Guidelines ^®). Soft tissue sarcoma. 2019 ; Accessed November 20, 2020 at: https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf
• 74 Nöbauer-Huhmann IM. Soft tissue tumors: imaging strategy for local primary diagnostics—manifestation, pearls and pitfalls in MRI. [in German]. Radiologe 2014; 54 (08) 803-818
• 75 Yahya Zaidi M, Cardona K. Post-operative surveillance in soft tissue sarcoma: using tumor-specific recurrence patterns to direct approach. Linchuang Zhongliuxue Zazhi 2018; 7 (04) 45
• 76 Tan MC, Brennan MF, Kuk D. et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 2016; 263 (03) 593-600
• 77 Park SY, Chung HW, Chae SY, Lee JS. Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance. Skeletal Radiol 2016; 45 (10) 1375-1384
• 78 Del Grande F, Subhawong T, Weber K, Aro M, Mugera C, Fayad LM. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T. Radiology 2014; 271 (02) 499-511
• 79 Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 1991; 157 (02) 353-358
• 80 Tagliafico A, Truini M, Spina B. et al. Follow-up of recurrences of limb soft tissue sarcomas in patients with localized disease: performance of ultrasound. Eur Radiol 2015; 25 (09) 2764-2770
• 81 Piperkova E, Mikhaeil M, Mousavi A. et al. Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas. Clin Nucl Med 2009; 34 (03) 146-150
• 82 Lim HJ, Johnny Ong CA, Tan JW, Ching Teo MC. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: a systematic review. Crit Rev Oncol Hematol 2019; 143: 1-13
• 83 Van Rijswijk CSP, Bloem JL. Follow-up imaging of soft tissue tumors. In: Vanhoenacker FM, Parizel PM, Gielen JL. eds. Imaging of Soft Tissue Tumors. 4th ed.. New York, NY: Springer International; 2017
• 84 Dürr HR, Rauh J, Baur-Melnyk A. et al. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients. BMC Cancer 2018; 18 (01) 304
• 85 Erfanian Y, Grueneisen J, Kirchner J. et al. Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial. Eur J Nucl Med Mol Imaging 2017; 44 (11) 1823-1831
• 86 Garner HW, Kransdorf MJ, Peterson JJ. Posttherapy imaging of musculoskeletal neoplasms. Radiol Clin North Am 2011; 49 (06) 1307-1323 , vii
• 87 Amini B, Murphy WA, Haygood TM. et al. Gadolinium-based contrast agents improve detection of recurrent soft-tissue sarcoma at MRI. Available at: https://pubs.rsna.org/doi/10.1148/rycan.2020190046. Accessed November 20, 2020
• 88 Papakonstantinou O, Isaac A, Dalili D, Noebauer-Huhmann IM. T2-weighted hypointense tumors and tumor-like lesions. Semin Musculoskelet Radiol 2019; 23 (01) 58-75
• 89 Pezeshk P, Alian A, Chhabra A. Role of chemical shift and Dixon based techniques in musculoskeletal MR imaging. Eur J Radiol 2017; 94: 93-100
• 90 Vanel D, Shapeero LG, Tardivon A, Western A, Guinebretière JM. Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection. Skeletal Radiol 1998; 27 (09) 505-510
• 91 Tagliafico AS, Bignotti B, Rossi F, Valdora F, Martinoli C. Local recurrence of soft tissue sarcoma: a radiomic analysis. Radiol Oncol 2019; 53 (03) 300-306
• 92 Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 38-79
• 93 Richardson ML, Zink-Brody GC, Patten RM, Koh WJ, Conrad EU. MR characterization of post-irradiation soft tissue edema. Skeletal Radiol 1996; 25 (06) 537-543
• 94 Garner HW, Kransdorf MJ, Bancroft LW, Peterson JJ, Berquist TH, Murphey MD. Benign and malignant soft-tissue tumors: posttreatment MR imaging. Radiographics 2009; 29 (01) 119-134
• 95 Bloem J, Vriens D, Krol A. et al. Therapy-related imaging findings in patients with sarcoma. Semin Musculoskelet Radiol 2020; 24 (06) 676-691
• 96 Vanel D, Shapeero LG, De Baere T. et al. MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 1994; 190 (01) 263-268
• 97 Biondetti PR, Ehman RL. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging. Radiology 1992; 183 (03) 845-848
• 98 Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 1987; 164 (01) 243-245
• 99 Hwang S, Lefkowitz R, Landa J. et al. Local changes in bone marrow at MRI after treatment of extremity soft tissue sarcoma. Skeletal Radiol 2009; 38 (01) 11-19
• 100 Stevens SK, Moore SG, Kaplan ID. Early and late bone-marrow changes after irradiation: MR evaluation. AJR Am J Roentgenol 1990; 154 (04) 745-750
• 101 Blomlie V, Rofstad EK, Skjønsberg A, Tverå K, Lien HH. Female pelvic bone marrow: serial MR imaging before, during, and after radiation therapy. Radiology 1995; 194 (02) 537-543
• 102 Casamassima F, Ruggiero C, Caramella D, Tinacci E, Villari N, Ruggiero M. Hematopoietic bone marrow recovery after radiation therapy: MRI evaluation. Blood 1989; 73 (06) 1677-1681
• 103 Peat BG, Bell RS, Davis A. et al. Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg 1994; 93 (05) 980-987
• 104 Baldini EH, Lapidus MR, Wang Q. et al. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol 2013; 20 (05) 1494-1499
• 105 Davies AM, Vanel D. Follow-up of musculoskeletal tumors. I. Local recurrence. Eur Radiol 1998; 8 (05) 791-799
• 106 Poon-Chue A, Menendez L, Gerstner MM, Colletti P, Terk M. MRI evaluation of post-operative seromas in extremity soft tissue sarcomas. Skeletal Radiol 1999; 28 (05) 279-282
• 107 Liu PT, Leslie KO, Beauchamp CP, Cherian SF. Chronic expanding hematoma of the thigh simulating neoplasm on gadolinium-enhanced MRI. Skeletal Radiol 2006; 35 (04) 254-257
• 108 Aoki T, Nakata H, Watanabe H. et al. The radiological findings in chronic expanding hematoma. Skeletal Radiol 1999; 28 (07) 396-401
• 109 Oka K, Yakushiji T, Sato H. et al. Ability of diffusion-weighted imaging for the differential diagnosis between chronic expanding hematomas and malignant soft tissue tumors. J Magn Reson Imaging 2008; 28 (05) 1195-1200
• 110 Reid JD, Kommareddi S, Lankerani M, Park MC. Chronic expanding hematomas. A clinicopathologic entity. JAMA 1980; 244 (21) 2441-2442
• 111 Nagano S, Yokouchi M, Setoguchi T. et al. Analysis of surgical site infection after musculoskeletal tumor surgery: risk assessment using a new scoring system. Sarcoma 2014; 2014: 645496
• 112 Soldatos T, Durand DJ, Subhawong TK, Carrino JA, Chhabra A. Magnetic resonance imaging of musculoskeletal infections: systematic diagnostic assessment and key points. Acad Radiol 2012; 19 (11) 1434-1443
• 113 Lalam RK, Cassar-Pullicino VN, Tins BJ. Magnetic resonance imaging of appendicular musculoskeletal infection. Top Magn Reson Imaging 2007; 18 (03) 177-191
• 114 Harish S, Chiavaras MM, Kotnis N, Rebello R. MR imaging of skeletal soft tissue infection: utility of diffusion-weighted imaging in detecting abscess formation. Skeletal Radiol 2011; 40 (03) 285-294
• 115 Bluemke DA, Fishman EK, Scott Jr WW. Skeletal complications of radiation therapy. Radiographics 1994; 14 (01) 111-121
• 116 Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol 2009; 38 (06) 579-584
• 117 O'Connell JX, English JC, Beauchamp CP, Connell DG. Intramuscular hypertrophic scar: an unusual complication following soft tissue sarcoma resection. Skeletal Radiol 1995; 24 (04) 305-307
• 118 Radtke C, Vogt PM. Nerve injuries and posttraumatic therapy [in German]. Unfallchirurg 2014; 117 (06) 539-555 ; quiz 556
• 119 Wolford LM, Stevao EL. Considerations in nerve repair. Proc Bayl Univ Med Cent 2003; 16 (02) 152-156
• 120 Kerimoglu U, Canyigit M. Paradoxic hypertrophy of the sciatic nerve in adult patients after above-knee amputation. Acta Radiol 2007; 48 (09) 1028-1031
• 121 Grieser T, Nöbauer-Huhmann IM. Postoperative and posttherapeutic changes after primary bone tumors : what's important for radiologists?. [in German]. Radiologe 2017; 57 (11) 938-957
• 122 Waters B, Panicek DM, Lefkowitz RA. et al. Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease. AJR Am J Roentgenol 2007; 188 (02) W193-W198
• 123 Ezuddin NS, Pretell-Mazzini J, Yechieli RL, Kerr DA, Wilky BA, Subhawong TK. Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy. Skeletal Radiol 2018; 47 (12) 1595-1606
• 124 Alpert JS, Boland P, Hameed M, Panicek DM. Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor. Skeletal Radiol 2018; 47 (01) 141-144
• 125 Kotnis NA, Grimer RJ, Davies AM, James SL. Magnetic resonance imaging appearances following hindquarter amputation for pelvic musculoskeletal malignancy. Skeletal Radiol 2009; 38 (12) 1137-1146
• 126 Kransdorf MJ, Murphey MD. Soft tissue tumors: post-treatment imaging. Radiol Clin North Am 2006; 44 (03) 463-472
• 127 Panicek DM, Schwartz LH, Heelan RT, Caravelli JF. Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm. Skeletal Radiol 1995; 24 (03) 185-190
• 128 Shapeero LG, Vanel D, Verstraete KL, Bloem JL. Fast magnetic resonance imaging with contrast for soft tissue sarcoma viability. Clin Orthop Relat Res 2002; (397) 212-227
• 129 Baur A, Huber A, Arbogast S. et al. Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol 2001; 11 (05) 828-833
• 130 Murphey MD, Arcara LK, Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics 2005; 25 (05) 1371-1395
• 131 Tateishi U, Hasegawa T, Beppu Y, Satake M, Moriyama N. Primary dedifferentiated liposarcoma of the retroperitoneum. Prognostic significance of computed tomography and magnetic resonance imaging features. J Comput Assist Tomogr 2003; 27 (05) 799-804
• 132 Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol 2000; 1 (03) 258-261
• 133 Lagrange JL, Ramaioli A, Chateau MC. et al; Radiation Therapist and Pathologist Groups of the Fédération Nationale des Centres de Lutte Contre le Cancer. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiology 2000; 216 (01) 197-205
• 134 Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 2001; 56 (01) 22-29
• 135 Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft-tissue and bone sarcoma. Radiology 1978; 129 (02) 501-508
• 136 Laskin WB, Silverman TA, Enzinger FM. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer 1988; 62 (11) 2330-2340